<p>Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Dec. 13, 2022 – With the U.S. grappling with an unprecedented opioid-related overdose crisis, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded a $1.8 million grant from the National Institutes of Health to research peer recovery support services for […]</p>
Share This Story
<p>Vaccines for this infection have been challenging to produce SAN ANTONIO (Dec. 13, 2022) — The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease […]</p>
Share This Story
<p>Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO – The Living Beyond Cancer A-Z: A Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center Symposium, featuring a full day of learning, empowerment and discovery, will be held Jan. 21 at UT Health San Antonio Long School of Medicine’s Holly Auditorium. “For cancer survivors, […]</p>
Share This Story
<p>Studies of cell channels lead to therapeutic antibodies in clinical trials Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 12, 2022) — Jean X. Jiang, PhD, whose pioneering research has given rise to potential bone cancer and brain injury therapeutics currently under evaluation in clinical trials, will be inducted as a Fellow of the National […]</p>
Share This Story
<p>Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Dec. 8, 2022 – The UT Health San Antonio School of Dentistry secured nearly $35 million in total research grants awarded during its 2022 fiscal year, which ended Aug. 31, setting a new record for the school’s research program. “Our school’s research mission focuses on finding solutions to […]</p>
Share This Story
<p>UT Health San Antonio contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu Hill Country MHDD contact: Kelsi Wilmot, 830-370-6302, kelsi8310@hillcountry.org SAN ANTONIO, Dec. 7, 2022 – Be Well Texas, a statewide initiative of UT Health San Antonio, and Hill Country Mental Health & Developmental Disabilities Centers have entered into an agreement to provide substance use disorder (SUD) treatment […]</p>
Share This Story
<p>The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 1, 2022) — The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, part of The University of Texas […]</p>
Share This Story
<p>Four-year, $2 million federal grant will more than double rural providers Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Dec. 1, 2022 – UT Health San Antonio has received a four-year, $2 million federal grant to expand its substance use disorder response program, Be Well Texas, to the state’s 178 rural counties that have limited or […]</p>
Share This Story
<p>Elacestrant may improve care of metastatic ER+/HER2- tumors Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 30, 2022) — Phase III results of EMERALD, a clinical trial evaluating a novel oral drug therapy for metastatic ER-positive/HER2-negative (ER+/HER2-) breast cancer, will be presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium (SABCS). Virginia Kaklamani, MD, […]</p>
Share This Story
<p>Metformin, SGLT-2 inhibitors and insulin resistance among career highlights Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 29, 2022) — Ralph A. DeFronzo, MD, professor of medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and deputy director of University Health’s Texas Diabetes Institute, will receive one of […]</p>
Share This Story